PaulDeep19131

VGW: 3.58 to 4.77 to Record Highs through Q4 2019

Long
TSXV:VGW   None
VGW has been oversold recently due to the Cannabis industry and the overall downfall of the sector. However, often times dollar stocks in the Cannabis industry (and in any sector as a matter of fact), typically are delayed in terms of their rebounds relative to the big players.

The rebound has started for the large players already in the sector and I expect VGW to rebound significantly - especially based on significantly beat revenue numbers from the last quarter. There will be heavy resistance from about 3.80-4.00, however, I expect by September, VGW should be near 4.50.

VGW revenue, profit, adjusted EBITDA all soared quarter to quarter. This is one of the few companies that have continuously grown from quarter to quarter with no sign of slowing due to their methodologies.

It is important to note that previous session bearishness on dollar stocks rarely get carried over session to session. Therefore, it is important to study for a good entry, but do not let a poor one day session influence you from missing out of a dollar stock all together.

- zSplit
Comment:
A little more bearish sentiment in the general markets since I posted this.

I don't believe however, VGW goes below 3.48.
Order cancelled:
Despite revenue beat the cannabis sector still has a ton of volatility to the downside. Even revenue beats cannot provide enough momentum in many stocks.

Wait for the bottom to form and enter on the re-test.
Comment:
Working its way up to ATHs with increased Cannabis sentiment.
Comment:
Rejected in September of 4.10 range.

Cannabis sector continues to get decimated. Despite excellent profitability and revenue growth, the sector continues to disappoint. VGW will be a stock for the future but with raging negative sentiment all across Cannabis and biotech, now is not the time to invent.

Trade closed since September.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.